首页|糖尿病黄斑水肿患者玻璃体腔注射康柏西普治疗效果的影响因素分析

糖尿病黄斑水肿患者玻璃体腔注射康柏西普治疗效果的影响因素分析

扫码查看
目的 探讨糖尿病黄斑水肿(DME)患者玻璃体腔注射康柏西普治疗效果的影响因素。方法 选取2019年6月至2021年5月于江西医学高等专科学校第一附属医院就诊的127例DME患者作为研究对象,全部患者均接受玻璃体腔注射康柏西普治疗,治疗7 d后参照相关标准评估患者治疗效果;设计基线资料调查表,询问并记录患者基线资料,将可能的因素纳入,经logistic回归分析找出DME患者玻璃体腔注射康柏西普治疗无效的影响因素。结果 127例DME患者经玻璃体腔注射康柏西普治疗,有36例无效,无效率为28。35%;单因素分析结果提示,吸烟史、糖化血红蛋白(HbA1c)水平、低密度脂蛋白(LDL)水平、高密度脂蛋白(HDL)水平升高是DME患者玻璃体腔注射康柏西普治疗效果的相关因素(P<0。05);多因素分析结果提示,吸烟史(β=0。900,OR=2。461,95%CI:1。118~5。413)、HbA1c水平升高(β=1。106,OR=3。023,95%CI:1。753~5。213)、LDL水平升高(β=0。576,OR=1。780,95%CI:1。167~2。713)是DME患者玻璃体腔注射康柏西普治疗无效的影响因素(OR>1,P<0。05);HDL水平升高(β=-3。699,OR=0。025,95%CI:0。003~0。191)是DME患者玻璃体腔注射康柏西普治疗无效的保护因素(OR<1,P<0。05)。结论 DME患者玻璃体腔注射康柏西普治疗无效可能受吸烟史、HbA1c水平升高、LDL水平升高、HDL水平降低影响。
Analysis of influencing factors on the therapeutic effect of intravitreal in-jection of Conbercept in patients with diabetic macular edema
Objective To investigate the factors influencing the therapeutic effect of intravitreal injection of Conbercept in patients with diabetic macular edema(DME).Methods A total of 127 DME patients treated in the First Affiliated Hospital of Jiangxi Medical College from June 2019 to May 2021 were selected as the study objects.All patients received intravitreal injection of Conbercept.The therapeutic effect of patients was evaluated according to relevant criteria after 7 days of treat-ment.The baseline data questionnaire was designed,and the baseline data of patients were queried and recorded.The pos-sible factors were included,and the influencing factors of the ineffective treatment of intravitreal injection of Conbercept in DME patients were identified by logistic regression analysis.Results Among 127 DME patients,36 cases(28.35%)were in-effectuated by intravitreal injection of Conbercept.Univariate analysis showed that smoking history,glycosylated hemoglobin(HbA1c)level,low density lipoprotein(LDL)level and high density lipoprotein(HDL)level were related factors to the thera-peutic effect of intravitreal injection of Conbercept in DME patients(P<0.05).The results of multivariate analysis suggested that smoking history(β=0.900,OR=2.461,95%CI:1.118-5.413),increased HbA1c level(β=1.106,OR=3.023,95%CI:1.753-5.213),increased LDL level(β=0.576,OR=1.780,95%CI:1.167-2.713)were the influential factors for the efficacy of intravitreal injection of Conbercept in DME patients(OR>1,P<0.05).Increased HDL level(β=-3.699,OR=0.025,95%CI:0.003-0.191)was a protective factor for ineffectiveness of intravitreal injection of Conbercept in DME patients(OR<1,P<0.05).Conclusion The efficacy of intravitreal injection of Conbercept in DME patients may be affected by smoking history,the increase of HbA1c level,the increase of LDL level and the decrease of HDL level.

Diabetic macular edemaVitreous bodyConberceptCurative effectInfluencing factors

占欣、何颖、施铁琴

展开 >

江西医学高等专科学校第一附属医院眼科特检科,江西上饶 334000

江西医学高等专科学校第一附属医院眼科门诊,江西上饶 334000

糖尿病黄斑水肿 玻璃体 康柏西普 疗效 影响因素

江西省卫生健康委科技计划项目

20202119

2024

中国当代医药
中国保健协会 当代创新(北京)医药科学研究院

中国当代医药

影响因子:1.215
ISSN:1674-4721
年,卷(期):2024.31(9)
  • 20